dimecres, 24 de setembre del 2014

Vital Therapies taps the market for $46M more




Vital Therapies raises another $46 million in a public stock offering as it works on its liver regeneration technology.






Vital Therapies (NSDQ:VTL) raised $46 million in a public offering of stock for its technique for the regeneration of liver tissue.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1mSWHcG

Cap comentari:

Publica un comentari a l'entrada